“With evolving technologies and emerging treatment options, this RFP is focused on defining subgroups of patients with a given diagnosis, understanding the role and improving detection of minimal residual disease (MRD) in hematological malignancies and using this information to guide treatment intervention,” explain the LLS about Quest for CURES, which is funded together with Celgene.
Find out more here.
The New Idea Award is a grant that privileges outstanding concepts. The award is attributed with the purpose of supporting innovative approaches that may fundamentally alter the understanding, diagnosis and/or treatment of blood cancers and related pre-malignant conditions. Applications for the New Idea Award are now closed.
Find out more here.
Learn more about lymphoma here: http://bit.ly/1UwWKe6
Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
